Advanced Enzyme Technologies · NSE: ADVENZYMES · BSE: 540025
Q3 FY26 results · Oct–Dec 2025
Advanced Enzyme Technologies reported revenue from operations of ₹171.95 crore (up 1.7% from Q3 FY25) and net profit of ₹43.18 crore (up 11.1% from Q3 FY25) for Q3 FY26 (Oct–Dec 2025), on a consolidated basis.
| Item | Q3 FY26 | Q3 FY25 | YoY | Q2 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 171.95 | 169.11 | +1.7% | 184.53 | −6.8% |
| Other income | 8.47 | 7.68 | +10.2% | 10.28 | −17.6% |
| Total income | 180.42 | 176.80 | +2.0% | 194.81 | −7.4% |
| Profit before tax | 58.29 | 53.02 | +9.9% | 59.54 | −2.1% |
| Net profit for the period | 43.18 | 38.88 | +11.1% | 44.73 | −3.5% |
| Attributable to shareholders of the company | 42.50 | 37.65 | +12.9% | 43.33 | −1.9% |
| EPS, basic (₹) | 3.80 | 3.36 | +13.1% | 3.87 | −1.8% |
| Net margin (%) | 25.1 | 23.0 | 24.2 |
| Item | Q3 FY26 | Q3 FY25 | YoY | Q2 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 95.58 | 100.87 | −5.2% | 115.75 | −17.4% |
| Other income | 1.29 | 1.43 | −9.4% | 3.08 | −58.0% |
| Total income | 96.88 | 102.30 | −5.3% | 118.83 | −18.5% |
| Profit before tax | 17.82 | 20.54 | −13.3% | 29.62 | −39.8% |
| Net profit for the period | 13.25 | 15.18 | −12.8% | 22.28 | −40.5% |
| EPS, basic (₹) | 1.18 | 1.36 | −13.2% | 1.99 | −40.7% |
| Net margin (%) | 13.9 | 15.1 | 19.3 |
Consolidated
- Filed with BSE
- 31 Jan 2026, 15:23 IST
- Board meeting
- 31 Jan 2026
- Period
- 01 Oct 2025 to 31 Dec 2025
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 31 Jan 2026, 15:23 IST
- Board meeting
- 31 Jan 2026
- Period
- 01 Oct 2025 to 31 Dec 2025
- Review status
- Unaudited
- Source
- XBRL filing on BSE